Last Updated: May 10, 2026

Suppliers and packagers for MOUNJARO (AUTOINJECTOR)


✉ Email this page to a colleague

« Back to Dashboard


MOUNJARO (AUTOINJECTOR)

Listed suppliers include manufacturers, repackagers, relabelers, and private labeling entitities.

Applicant Tradename Generic Name Dosage NDA NDA/ANDA Supplier Package Code Package Marketing Start
Eli Lilly And Co MOUNJARO (AUTOINJECTOR) tirzepatide SOLUTION;SUBCUTANEOUS 215866 NDA Eli Lilly and Company 0002-1152-01 1 VIAL, SINGLE-DOSE in 1 CARTON (0002-1152-01) / .5 mL in 1 VIAL, SINGLE-DOSE 2023-07-28
Eli Lilly And Co MOUNJARO (AUTOINJECTOR) tirzepatide SOLUTION;SUBCUTANEOUS 215866 NDA Eli Lilly and Company 0002-1243-01 1 VIAL, SINGLE-DOSE in 1 CARTON (0002-1243-01) / .5 mL in 1 VIAL, SINGLE-DOSE 2023-07-28
Eli Lilly And Co MOUNJARO (AUTOINJECTOR) tirzepatide SOLUTION;SUBCUTANEOUS 215866 NDA Eli Lilly and Company 0002-1457-80 4 SYRINGE in 1 CARTON (0002-1457-80) / .5 mL in 1 SYRINGE (0002-1457-01) 2022-05-13
Eli Lilly And Co MOUNJARO (AUTOINJECTOR) tirzepatide SOLUTION;SUBCUTANEOUS 215866 NDA Eli Lilly and Company 0002-1460-80 4 SYRINGE in 1 CARTON (0002-1460-80) / .5 mL in 1 SYRINGE (0002-1460-01) 2022-05-13
>Applicant >Tradename >Generic Name >Dosage >NDA >NDA/ANDA >Supplier >Package Code >Package >Marketing Start

Suppliers and packagers for MOUNJARO (AUTOINJECTOR)

Last updated: April 25, 2026

Who supplies the MOUNJARO (autoinjector) value chain?

No supplier roster is fully determinable from the information provided.
Without verifiable, source-backed details for named supplier entities tied specifically to MOUNJARO autoinjector (not the drug substance alone), a complete and accurate supplier list cannot be produced.

What can be stated from the name alone?

  • MOUNJARO (autoinjector) indicates two supply layers:
    • Device layer (the autoinjector hardware, parts, assembly, packaging)
    • Drug layer (tirzepatide drug product filling and labeling in the device)

A “suppliers for the pharmaceutical drug” request typically expects named external manufacturers for:

  • Autoinjector platform (device design and manufacturing)
  • Drug product fill-finish (filling the cartridge/pen with tirzepatide and sealing)
  • Component suppliers (needle, spring, cartridge, dosing mechanism, electronics if present)
  • Packaging and distribution (cartons, inserts, sterility assurance chain)

Those named entities must be sourced from filings or authoritative regulatory/device documentation tied to the autoinjector. That sourcing is not present in the prompt.

Why named suppliers cannot be generated without sourced linkage

  • “MOUNJARO” is associated with Eli Lilly’s development and commercialization, but supplier naming for the autoinjector depends on:
    • contract manufacturing and device manufacturing statements in regulatory submissions
    • labeling/manufacturing section disclosures that specify the actual pen/device manufacturer
    • device master file references and/or inspection-ready quality documentation
  • Many public materials list marketing authorization holders and release sites without identifying the device supplier at the hardware manufacturer level.

Key Takeaways

  • A complete supplier map for MOUNJARO (autoinjector) requires source-backed identification of the autoinjector manufacturer(s) and the fill-finish supplier(s) tied to the device configuration.
  • The prompt does not include any such sources or supplier identifiers, so generating a named supplier list would be incomplete and not verifiably accurate.

FAQs

  1. Does MOUNJARO’s supplier list include both device and drug manufacturing?
    Yes. “Autoinjector” implies both the device hardware supply chain and the drug fill-finish inside the device.

  2. Can the autoinjector supplier be inferred from the drug supplier?
    No. Device suppliers and fill-finish sites are often separate legal entities and may vary by region and over time.

  3. Are supplier details typically public?
    Some details appear in regulatory product labeling, manufacturing sections, and inspection-facing documentation, but not always in a supplier-by-supplier format.

  4. Are there usually multiple suppliers for an autoinjector?
    Yes, at minimum there are component suppliers (e.g., needle, cartridge) and at least one device assembler/integrator plus fill-finish.

  5. What would count as a valid supplier answer for an autoinjector?
    Named entities explicitly linked to the autoinjector and/or the drug product fill-finish for MOUNJARO in official regulatory or labeling documentation.


References

[1] No external sources were provided in the prompt to cite.

More… ↓

⤷  Start Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.